首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Simultaneous transplantation of hematopoietic stem cells and a vascularized composite allograft leads to tolerance
【24h】

Simultaneous transplantation of hematopoietic stem cells and a vascularized composite allograft leads to tolerance

机译:同时移植造血干细胞和带血管的复合同种异体移植物导致耐受

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: We have previously demonstrated that tolerance to a vascularized composite allograft (VCA) can be achieved after the establishment of mixed chimerism. We test the hypothesis that tolerance to a VCA in our dog leukocyte antigen-matched canine model is not dependent on the previous establishment of mixed chimerism and can be induced coincident with hematopoietic cell transplantation (HCT). METHODS: Eight dog leukocyte antigen-matched, minor antigen mismatched dogs received 200 cGy of radiation and a VCA transplant. Four dogs received donor bone marrow at the time of VCA transplantation (group 1), whereas a second group of four dogs did not (group 2). All recipients received a limited course of postgrafting immunosuppression. All dogs that received HCT and VCA were given donor, third-party, and autologous skin grafts. RESULTS: All group 1 recipients were tolerant to their VCA (>62 weeks). Three of the four dogs in group 2 rejected their VCA transplants after the cessation of immunosuppression. Biopsies obtained from the muscle and skin of VCA from group 1 showed few infiltrating cells compared with extensive infiltrates in biopsies of VCA from group 2. Compared with autologous skin and muscle, elevated levels of CD3+ FoxP3+ T-regulatory cells were found in the skin and muscle obtained from the VCA of HCT recipients. All group 1 animals were tolerant to their donor skin graft and promptly rejected the third-party skin grafts. CONCLUSION: These data demonstrated that donor-specific tolerance to all components of the VCA can be established through simultaneous nonmyeloablative allogeneic HCT and VCA transplantation protocol.
机译:背景:我们以前已经证明,建立混合嵌合体后可以实现对血管化复合同种异体移植物(VCA)的耐受性。我们测试了这样的假说,即在我们的狗白细胞抗原匹配的犬模型中对VCA的耐受性不依赖于先前建立的混合嵌合体,并且可以在造血细胞移植(HCT)的同时被诱导。方法:八只狗白细胞抗原匹配的狗,次要抗原不匹配的狗接受了200 cGy的辐射并进行了VCA移植。在VCA移植时,四只狗接受了供体骨髓(第1组),而第二只四只狗则没有(第2组)。所有接受者均接受有限的移植后免疫抑制过程。所有接受HCT和VCA的狗均接受了供体,第三方和自体皮肤移植。结果:所有第1组接受者均耐受其VCA(> 62周)。在停止免疫抑制后,第二组的四只狗中的三只拒绝了他们的VCA移植。与第2组VCA活检相比,从第1组VCA肌肉和皮肤获得的活检显示浸润细胞很少,与自体皮肤和肌肉相比,在皮肤和皮肤中发现CD3 + FoxP3 + T调节细胞水平升高。从HCT接受者的VCA获得的肌肉。第1组的所有动物均耐受其供体皮肤移植,并迅速拒绝了第三方皮肤移植。结论:这些数据表明,通过同时进行非清髓性异基因HCT和VCA移植方案,可以建立对VCA所有成分的供体特异性耐受。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号